|
|
||||||||
From the Laboratory of Neurogenetics of Motion (E.R., I.T., M.T., M.-J.D., B.B.), Centre for the Study of Brain Diseases, Centre de Recherche du Centre Hospitalier de lUniversité de Montréal (CHUM), Université de Montréal; Clinique des Maladies Neuromusculaires (J.M., B.B.), Carrefour de Santé de Jonquière, Saguenay; Service de Neurologie (N.C., N.D.), Centre Hospitalier Affilié Universitaire de Québec, Hôpital Enfant-Jésus, Université Laval; and Laboratoire de Génétique Humaine (J.P.), Centre Hospitalier Universitaire de Québec, pavillon CHUL, Québec, Canada.
Address correspondence and reprint requests to Dr. Bernard Brais, Laboratoire de Neurogénétique, M4211-L3 Hôpital Notre-Dame-CHUM, 1560 Sherbrooke est, Montréal, Québec, Canada H2L 4M1 Bernard.Brais{at}umontreal.ca
Background: Myotonia is observed in classic congenital myotonia caused by CLCN1 mutations and in sodium-channel myotonia (SCM) due to SCN4A mutations.
Methods: We assessed 66 electrically proven cases of myotonia belonging to 17 French-Canadian families living in the Saguenay Lac St-Jean area of Quebec, a region well known for its genetic founder effects. The CLCN1 gene was sequenced in one affected member of each family. SCN4A exons with known SCM mutations were subsequently sequenced in families where no CLCN1 mutations were found.
Results: Six families, 33% of cases (22/66), presenting classic congenital myotonia phenotypes were found to carry two previously identified CLCN1 mutations. In the other 11 families comprising 66% of cases (44/66), a new dominant SCN4A mutation in exon 24 (M1476I) was uncovered and segregated with a variable SCM phenotype. Although all carriers of this novel mutation had electrical myotonia, some were asymptomatic (25%) and age at onset was variable in the others (5 to 67, mean 21). Cold aggravated myotonia was observed in 41% of cases and painful myotonia in 18%. Additional features observed include aggravation of symptoms with pregnancies (7%), localized muscle swelling (2%), myotonic reactions to anesthesia (2%), and food-induced paralysis (2%).
Conclusions: This cohort is the largest described with a variable sodium-channel myotonia phenotype caused by a single SCN4A mutation. The clinical variability observed in this cohort underlines the phenotypic heterogeneity of SCN4A mutations and suggests that variants in other genes likely modulate clinical expression.
GLOSSARY: DM1 = myotonic dystrophy type I; HYPP = hyperkaliemic periodic paralysis; PMC = paramyotonia congenita; SCM = sodium-channel myotonia; SLSJ = Saguenay Lac Saint-Jean.
Supplemental data at www.neurology.org
Disclosure: The authors report no conflicts of interest.
Received December 27, 2006. Accepted in final form May 30, 2007.
This article has been cited by other articles:
![]() |
T. Carle, E. Fournier, D. Sternberg, B. Fontaine, and N. Tabti Cold-induced disruption of Na+ channel slow inactivation underlies paralysis in highly thermosensitive paramyotonia J. Physiol., April 15, 2009; 587(8): 1705 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Estacion, S. D. Dib-Hajj, P. J. Benke, R. H. M. te Morsche, E. M. Eastman, L. J. Macala, J. P. H. Drenth, and S. G. Waxman NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders J. Neurosci., October 22, 2008; 28(43): 11079 - 11088. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |